Neoadjuvant Chemoradiotherapy improves oncological results in resectable and borderline resectable Pancreatic Carcinomas, but not Overall Survival in resectable ones Results of the Dutch PREOPANC Study

被引：0
|
作者：
Hermann, Robert Michael [1 ]
Christiansen, Hans [2 ]
机构：
[1] Zentrum Strahlentherapie, Mozartstr 30, D-26655 Westerstede, Germany
[2] Hannover Med Sch, Klin Strahlentherapie & Spezielle Onkol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2021年 / 197卷 / 01期
关键词：
GEMCITABINE;
D O I：
10.1007/s00066-020-01717-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [41] Surgery after Neoadjuvant Immuno-Chemoradiotherapy in (Borderline) Resectable NSCLC: Results from the INCREASE Trial
    Dickhoff, C.
    Heineman, D.
    Schneiders, F.
    Houda, I.
    Veltman, J.
    Hashemi, S.
    Fransen, M.
    Radonic, T.
    Bartelink, I.
    Meijboom, L.
    Oprea-Lager, D.
    Bouwhuis, N.
    de Gruijl, T.
    Senan, S.
    Bahce, I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S56 - S57
  • [42] Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
    Choi, Jin G.
    Nipp, Ryan D.
    Tramontano, Angela
    Ali, Ayman
    Zhan, Tiannan
    Pandharipande, Pari
    Dowling, Emily C.
    Ferrone, Cristina R.
    Hong, Theodore S.
    Schrag, Deborah
    Fernandez-Del Castillo, Carlos
    Ryan, David P.
    Kong, Chung Yin
    Hur, Chin
    ONCOLOGIST, 2019, 24 (07): : 945 - 954
  • [43] Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma
    Mokdad, Ali A.
    Minter, Rebecca M.
    Yopp, Adam C.
    Porembka, Matthew R.
    Wang, Sam C.
    Zhu, Hong
    Augustine, Mathew M.
    Mansour, John C.
    Choti, Michael A.
    Polanco, Patricio M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12): : 1468 - 1475
  • [44] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreatic cancer (BRPC): Updated results.
    Kanji, Zaheer S.
    Rocha, Flavio G.
    Edwards, Alicia M.
    Mandelson, Margaret T.
    Lin, Bruce S.
    Kozarek, Richard A.
    Rose, J. Bart B.
    Biehl, Thomas R.
    Alseidi, Adnan
    Helton, Scott
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study
    Suto, Hironobu
    Fuke, Takuro
    Matsukawa, Hiroyuki
    Ando, Yasuhisa
    Oshima, Minoru
    Nagao, Mina
    Takahashi, Shigeo
    Shibata, Toru
    Yamana, Hiroki
    Kamada, Hideki
    Kobara, Hideki
    Okuyama, Hiroyuki
    Kumamoto, Kensuke
    Okano, Keiichi
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [46] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Akhil Chawla
    George Molina
    Linda M. Pak
    Michael Rosenthal
    Joseph D. Mancias
    Thomas E. Clancy
    Brian M. Wolpin
    Jiping Wang
    Annals of Surgical Oncology, 2020, 27 : 1191 - 1200
  • [47] Neoadjuvant Therapy is Associated with Improved Survival in Borderline-Resectable Pancreatic Cancer
    Chawla, Akhil
    Molina, George
    Pak, Linda M.
    Rosenthal, Michael
    Mancias, Joseph D.
    Clancy, Thomas E.
    Wolpin, Brian M.
    Wang, Jiping
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (04) : 1191 - 1200
  • [48] Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
    Eva Versteijne
    Casper H. J. van Eijck
    Cornelis J. A. Punt
    Mustafa Suker
    Aeilko H. Zwinderman
    Miriam A. C. Dohmen
    Karin B. C. Groothuis
    Oliver R. C. Busch
    Marc G. H. Besselink
    Ignace H. J. T. de Hingh
    Albert J. ten Tije
    Gijs A. Patijn
    Bert A. Bonsing
    Judith de Vos-Geelen
    Joost M. Klaase
    Sebastiaan Festen
    Djamila Boerma
    Joris I. Erdmann
    I. Quintus. Molenaar
    Erwin van der Harst
    Marion B. van der Kolk
    Coen R. N. Rasch
    Geertjan van Tienhoven
    Trials, 17
  • [49] Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre
    Itchins, M.
    Arena, J.
    Nahm, C. B.
    Rabindran, J.
    Kim, S.
    Gibbs, E.
    Bergamin, S.
    Chua, T. C.
    Gill, A. J.
    Maher, R.
    Diakos, C.
    Wong, M.
    Mittal, A.
    Hruby, G.
    Kneebone, A.
    Pavlakis, N.
    Samra, J.
    Clarke, S.
    EJSO, 2017, 43 (09): : 1711 - 1717
  • [50] Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
    Versteijne, Eva
    van Eijck, Casper H. J.
    Punt, Cornelis J. A.
    Suker, Mustafa
    Zwinderman, Aeilko H.
    Dohmen, Miriam A. C.
    Groothuis, Karin B. C.
    Busch, Oliver R. C.
    Besselink, Marc G. H.
    de Hingh, Ignace H. J. T.
    ten Tije, Albert J.
    Patijn, Gijs A.
    Bonsing, Bert A.
    de Vos-Geelen, Judith
    Klaase, Joost M.
    Festen, Sebastiaan
    Boerma, Djamila
    Erdmann, Joris I.
    Molenaar, I. Quintus
    van der Harst, Erwin
    van der Kolk, Marion B.
    Rasch, Coen R. N.
    van Tienhoven, Geertjan
    TRIALS, 2016, 17
12345